Tower Research Capital LLC (TRC) - SENSEI BIOTHERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,807
-31.8%
7,259
-2.8%
0.00%
Q2 2023$8,516
+283766.7%
7,470
+282.1%
0.00%
Q1 2023$30.0%1,955
-7.3%
0.00%
Q4 2022$3
-100.0%
2,110
-56.4%
0.00%
Q3 2022$7,000
-30.0%
4,837
+10.4%
0.00%
Q2 2022$10,000
-9.1%
4,382
-7.8%
0.00%
Q1 2022$11,000
-47.6%
4,751
+31.1%
0.00%
Q4 2021$21,000
+162.5%
3,623
+367.5%
0.00%
Q3 2021$8,000
-42.9%
775
-45.0%
0.00%
Q2 2021$14,000
+75.0%
1,410
+147.4%
0.00%
Q1 2021$8,0005700.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Newtyn Management, LLC 415,000$942,0000.18%
RA Capital Management 723,549$1,642,0000.04%
Duquesne Family Office 100,000$227,0000.02%
LEO BROKERAGE, LLC 14,845$34,0000.01%
Ergoteles LLC 93,598$212,0000.01%
Virtu Financial LLC 11,223$25,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 37,900$86,0000.00%
Renaissance Technologies 247,000$561,0000.00%
UBS Group AG 13,463$31,0000.00%
TWO SIGMA INVESTMENTS, LP 38,776$88,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders